Fusion's Limit Shattered: Biotech Convergence Reshapes Energy and Health

China's EAST reactor has pierced the Greenwald density limit, sustaining plasma 1.3-1.65 times beyond thresholds, unlocking fusion's grid-scale potential. This fuses with biotech surges in cell-free manufacturing and bioprinting, signaling a $500B R&D pivot. Systemic shifts loom for energy security and precision medicine amid resource strains.